Trial intelligence / Profile preview

Adjunctive Maintenance Therapy With Oral ELND005 in Bipolar I Disorder

2012-001935-30Phase 2Completed

Sponsor
Elan
Start
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in bipolar I disorder comparing ELND005 adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Time to recurrence of any mood episode. Started Sep 2012; status: completed.

02

Drugs

scyllo-inositol
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on 2012-001935-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001935-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call